Wagener Max, Boeddinghaus Jasper, Gaemperli Oliver, Räber Lorenz, Nietlispach Fabian, Meier Pascal, Muller Olivier, Weilenmann Daniel, Jeger Raban
Department of Cardiology, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland.
Department of Cardiology, University Hospital Galway, H91 YR71 Galway, Ireland.
J Clin Med. 2022 Dec 15;11(24):7459. doi: 10.3390/jcm11247459.
Considering the global burden of cardiovascular disease, we analysed trends in interventional coronary and structural procedures over the past 16 years (2005-2021), using continuous data from the Swiss national registry.
Based on a standardised questionnaire, data on coronary and structural interventions in Switzerland were assessed by the Working Group Interventional Cardiology of the Swiss Society of Cardiology (SSC). Here, we analysed the trend of annually performed interventions from 2005 to 2021 in Switzerland and the impact of the COVID-19 pandemic.
We observed a constant increase in the total number of cases (including coronary angiographies (CA) and percutaneous coronary interventions (PCI)) from 36,436 cases in 2005 to 56,555 cases in 2021 (+55%). With 18 cases in 2007, TAVI procedures have increased to 2004 cases in 2021. During the early phase of the COVID-19 pandemic in 2020, a slight decrease in CAs and PCIs of 9.15% was observed. In contrast, we did not observe an impact of the COVID-19 pandemic on the number of no TAVI procedures. Most importantly, all cause in-hospital mortality for coronary interventions before and during the peak of the COVID-19 pandemic was comparable (1.4% vs. 1.3%).
Over a 16-year period, we observed an upward trend in diagnostic and therapeutic procedures for coronary as well as structural heart disease, with only a small short-term impact of the COVID-19 pandemic on interventions and a similar procedure-related in-hospital-mortality in Switzerland.
考虑到心血管疾病的全球负担,我们利用瑞士国家登记处的连续数据,分析了过去16年(2005 - 2021年)冠状动脉介入和结构性手术的趋势。
基于一份标准化问卷,瑞士心脏病学会(SSC)介入心脏病学工作组评估了瑞士冠状动脉和结构性干预的数据。在此,我们分析了2005年至2021年瑞士每年进行的干预趋势以及新冠疫情的影响。
我们观察到病例总数(包括冠状动脉造影(CA)和经皮冠状动脉介入治疗(PCI))持续增加,从2005年的36436例增加到2021年的56555例(增长55%)。经导管主动脉瓣置入术(TAVI)手术从2007年的18例增加到2021年的2004例。在2020年新冠疫情早期,观察到CA和PCI略有下降,降幅为9.15%。相比之下,我们未观察到新冠疫情对非TAVI手术数量有影响。最重要的是,新冠疫情高峰期之前和期间冠状动脉介入治疗的全因住院死亡率相当(1.4%对1.3%)。
在16年期间,我们观察到冠状动脉以及结构性心脏病的诊断和治疗手术呈上升趋势,在瑞士,新冠疫情对干预措施仅有微小的短期影响,且与手术相关的住院死亡率相似。